SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.

At this time point, the organoid proliferation defect is not yet significant ( Fig. 3, A and F ) and, therefore, this analysis could enable the identification of pathways that are potentially the cause, rather than the consequence, of the impaired proliferation phenotype.

also in 316 other papers